Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (21-30 of 350) with videos related to

Pageof 35
Sort By:
Journal of Crohn'S & Colitis|August 28, 2025
Optimizing the switch from escalated intravenous to subcutaneous infliximab: a population pharmacokinetics-pharmacodynamics studyZhigang Wang, Marc Ferrante, Séverine Vermeire, et al.
Therapeutic Advances in Gastroenterology|June 18, 2019
New biologics and small molecules in inflammatory bowel disease: an updateJoão Sabino, Bram Verstockt, Séverine Vermeire, et al.
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: biomarker predictors of non-response to TNFα antagonists - the quest continues. Authors' replyBram Verstockt, Séverine Vermeire, Marc Ferrante, et al.
Current Problems in Diagnostic Radiology|February 2, 2019
MRI of the Penis: Indications, Anatomy, and PathologyLong H Tu, Mike Spektor, Marc Ferrante, et al.
Expert Opinion on Biological Therapy|November 8, 2016
Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel diseaseBram Verstockt, Gert Van Assche, Séverine Vermeire, et al.
Rare Tumors|July 9, 2014
Schwannoma of the cervical esophagusMarc Ferrante, Arfa Khan, Cathy Fan, et al.
Inflammatory Intestinal Diseases|February 28, 2022
Assessment of Endoscopic Disease Activity in Ulcerative Colitis: Is Simplicity the Ultimate Sophistication?Ala I Sharara, Maher Malaeb, Matthias Lenfant, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Reply to Dr. Caprilli et al.'s letterMarc Ferrante, Séverine Vermeire, Gert Van Assche, et al.
Journal of Gastroenterology|March 21, 2018
New treatment options for inflammatory bowel diseasesBram Verstockt, Marc Ferrante, Séverine Vermeire, et al.
Scandinavian Journal of Gastroenterology|September 27, 2018
When IBD is not IBDBram Verstockt, Séverine Vermeire, Gert Van Assche, et al.
Pageof 35

Showing results (21-30 of 350) with videos related to

Sort By:
Pageof 35
Journal of Crohn'S & Colitis|August 28, 2025
Optimizing the switch from escalated intravenous to subcutaneous infliximab: a population pharmacokinetics-pharmacodynamics studyZhigang Wang, Marc Ferrante, Séverine Vermeire, et al.
Therapeutic Advances in Gastroenterology|June 18, 2019
New biologics and small molecules in inflammatory bowel disease: an updateJoão Sabino, Bram Verstockt, Séverine Vermeire, et al.
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: biomarker predictors of non-response to TNFα antagonists - the quest continues. Authors' replyBram Verstockt, Séverine Vermeire, Marc Ferrante, et al.
Current Problems in Diagnostic Radiology|February 2, 2019
MRI of the Penis: Indications, Anatomy, and PathologyLong H Tu, Mike Spektor, Marc Ferrante, et al.
Expert Opinion on Biological Therapy|November 8, 2016
Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel diseaseBram Verstockt, Gert Van Assche, Séverine Vermeire, et al.
Rare Tumors|July 9, 2014
Schwannoma of the cervical esophagusMarc Ferrante, Arfa Khan, Cathy Fan, et al.
Inflammatory Intestinal Diseases|February 28, 2022
Assessment of Endoscopic Disease Activity in Ulcerative Colitis: Is Simplicity the Ultimate Sophistication?Ala I Sharara, Maher Malaeb, Matthias Lenfant, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Reply to Dr. Caprilli et al.'s letterMarc Ferrante, Séverine Vermeire, Gert Van Assche, et al.
Journal of Gastroenterology|March 21, 2018
New treatment options for inflammatory bowel diseasesBram Verstockt, Marc Ferrante, Séverine Vermeire, et al.
Scandinavian Journal of Gastroenterology|September 27, 2018
When IBD is not IBDBram Verstockt, Séverine Vermeire, Gert Van Assche, et al.
Pageof 35